Skip to content

Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 71% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 71% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money.

Post earnings trade setups: Zoom, Taylor Wimpey, Abercrombie & Fitch

With Q4 earnings season still underway, Zoom, Taylor Wimpey, Abercrombie & Fitch provide us with interesting trading opportunities.

Source: ProRealTime

This article looks at some of the big movers off the back of recent earnings announcements to try and find stocks that seem to provide a good trading opportunity. Typically, earnings announcements and trading statements will drive a shift or enhancement of market sentiment. While many see earnings as a significant risk when holding a stock, placing trades in the wake of such events allows for greater confidence that all market knowledge has been factored into current prices.

Zoom Video Communications

Zoom shares enjoyed a year to remember in 2020, with the stock gaining over 400% over the course of the year. However, fears are growing for this lockdown favourite, with the stock tumbling alongside other tech names despite a surge on the release of their blockbuster fourth-quarter figures. That takes us back towards the key $31750 support level. A break below there would bring about a wider bearish view for this stock. However, until that happens there is still a good chance we see the bulls step in once again from here.

Source: ProRealTime

Taylor Wimpey

Housing stocks received a boost from the chancellor’s latest budget, with Taylor Wimpey no exception to that. Gains over the course of Thursday in particular too price up through the £1.76 resistance level for the first time in almost a year. With price having pulled sharply back in the hours that followed that break, we are looking for an ability to sustain price action above horizontal and trendline resistance. As such, the key here is whether we can finally break from this consolidation phase, with a failure to take out this peak signaling the potential continuation of that multi-month sideways trajectory.

Source: ProRealTime

Abercrombie & Fitch

Abercrombie & Fitch shares have been on a remarkably consistent run over the course of the past year, with the initial Covid pullback giving way to an impressive uptrend. This has taken us up into the 2019 peak of $29.10. A break through that historical resistance level would bring greater confidence of a bullish continuation. On the flipside, a decline through trendline and $26.16 support would bring an end to the ongoing uptrend and bring a more concerning outlook for the stock.

Source: ProRealTime

Act on share opportunities today

Go long or short on thousands of international stocks with spread bets and CFDs.

  • Get full exposure for a comparatively small deposit
  • Trade on spreads from just 0.1%
  • Get greater order book visibility with direct market access

See opportunity on a stock?

Try a risk-free trade in your demo account, and see whether you’re on to something.

  • Log in to your demo
  • Take your position
  • See whether your hunch pays off

See opportunity on a stock?

Don’t miss your chance – upgrade to a live account to take advantage.

  • Trade a huge range of popular stocks
  • Analyse and deal seamlessly on fast, intuitive charts
  • See and react to breaking news in-platform

See opportunity on a stock?

Don’t miss your chance. Log in to take advantage while conditions prevail.

Related articles

Live prices on most popular markets

  • Equities
  • Indices
  • Forex
  • Commodities
website terms and agreements. Prices are indicative only. All share prices are delayed by at least 15 minutes.

" >


Prices above are subject to our website terms and agreements. Prices are indicative only. All share prices are delayed by at least 15 minutes.

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.

Plan your trading week

Get the week’s market-moving news sent directly to your inbox every Monday. The Week Ahead gives you a full calendar of upcoming economic events, as well as commentary from our expert analysts on the key markets to watch.


You might be interested in…

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of spread betting and CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.


This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.